Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat

AIMS: Recent studies have shown that mineralocorticoid receptor antagonists (MRAs) can decrease mortality in patients with heart failure; however, the application of MRAs in current clinical practice is limited because of adverse effects such as hyperkalemia that occur with treatment. Therefore, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Chang, Mao, Yu-Cheng, Qi, Su-fen, Song, Kai, Wang, Hong-Fei, Zhang, Zi-yan, Tian, Qing-Bao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657990/
https://www.ncbi.nlm.nih.gov/pubmed/38028498
http://dx.doi.org/10.3389/fcvm.2023.1236008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657990/
https://www.ncbi.nlm.nih.gov/pubmed/38028498
http://dx.doi.org/10.3389/fcvm.2023.1236008

Ejemplares similares